Analytical Data
-
Gene name
MMP25
- Application
-
Alternative Names
MT6-MMP; MMP25; MMPL1; MT-MMP6; Matrix Metallopeptidase Like 1; Leukolysin; Membrane-type matrix metalloproteinase 6; Membrane-type-6 matrix metalloproteinase
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NPA2
-
Expression Region
Tyr108~Ile313
-
Molecular Weight
27kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MMP25, also known as matrix metalloproteinase-25, is a member of the matrix metalloproteinase (MMP) family, which is crucial for the degradation and remodeling of extracellular matrix components. This enzymatic activity plays a significant role in numerous physiological and pathological processes, including tissue repair, embryogenesis, and tumor metastasis. Research has indicated that MMP25 is involved in various diseases, particularly in the context of cancers and inflammatory disorders, making it a potential target for therapeutic interventions. The production and characterization of recombinant MMP25 protein have garnered interest to elucidate its biological functions and regulatory mechanisms. By generating a recombinant version of MMP25, scientists can study its enzymatic properties, substrate specificity, and interaction with inhibitors, thereby enhancing the understanding of its role in disease progression. Additionally, this research may lead to the identification of novel biomarkers for disease diagnosis and the development of targeted strategies for therapy. Overall, the investigation of recombinant MMP25 protein is pivotal in advancing knowledge in matrix biology and its implications in human health and disease.
